SARS-CoV-2 3CLpro-IN-14 (11j) is a potent, orally bioavailable inhibitor targeting the SARS-CoV-2 3CL protease. It exhibits strong antiviral activity in vitro with an EC50 of 0.18 µM in Vero E6 cells and demonstrates high selectivity (CC50 >50 µM). This compound is a valuable tool for researching coronavirus replication mechanisms and developing antiviral therapies.
Molekulargewicht:
735.84
Formel:
C34H40F3N5O6S2
Target-Kategorie:
SARS-CoV
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
